Huyết khối gây tắc lại Stent và vai trò của thuốc kháng kết tập tiểu cầu
Tóm tắt
Huyết khối gây tắc lại Stent và vai trò của thuốc kháng kết tập tiểu cầuTài liệu tham khảo
1. Lemesle, G., et al., Stent thrombosis in 2008: definition, predictors, prognosis and treatment. Arch Cardiovasc Dis, 2008. 101(11-12): p. 769-77.
2. Iakovou, I., et al., Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA, 2005. 293(17): p. 2126-30.
3. Schatz, R.A., et al., Clinical experience with the Palmaz-Schatz coronary stent. Initial results of a multicenter study. Circulation, 1991. 83(1): p. 148-61.
4. Serruys, P.W., et al., Angiographic follow-up after placement of a self-expanding coronary-artery stent. N Engl J Med, 1991. 324(1): p. 13-7.
5. Kastrati, A., et al., Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med, 2007. 356(10): p. 1030-9.
6. Mauri, L., et al., Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med, 2007. 356(10): p. 1020-9.
7. Ong, A.T., et al., Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation. J Am Coll Cardiol, 2005. 45(6): p. 947-53.
8. Stone, G.W., et al., Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med, 2007. 356(10): p. 998-1008.
9. Moses, J.W., et al., Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med, 2003. 349(14): p. 1315-23.
10. Lagerqvist, b., et al., Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med, 2007. 356(10): p. 1009-19.
11. De la Torre-Hernandez, J.M., et al., Drug-eluting stent thrombosis: results from the multicenter Spanish registry ESTROFA (Estudio ESpanol sobre TROmbosis de stents FArmacoactivos). J Am Coll Cardiol, 2008. 51(10): p. 986-90.
12. Daemen, J., et al., Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet, 2007. 369(9562): p. 667-78.
13. Parodi, G., et al., Effectiveness of primary percutaneous coronary interventions for stent thrombosis.
Am J Cardiol, 2009. 103(7): p. 913-6.
14. Siller-Matula, J., et al., Thienopyridines in cardiovascular disease: focus on clopidogrel resistance.
Thromb Haemost, 2007. 97(3): p. 385-93.
15. Steinhubl, S.R., et al., Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA, 2002. 288(19): p. 2411-20.
16. Sibbing, d. and S. Massberg, Dual antiplatelet treatment after stenting: is longer better? Lancet, 2014. 384(9954): p. 1553-5.
17. Investigators, C.-O., et al., Dose comparisons of clopidogrel and aspirin in acute coronary syndromes.
N Engl J Med, 2010. 363(10): p. 930-42.
18. Mehran, R., et al., Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study. Lancet, 2013. 382(9906): p. 1714-22.
19. Brar, S.S., et al., Impact of platelet reactivity on clinical outcomes after percutaneous coronary intervention. A collaborative meta-analysis of individual participant data. J Am Coll Cardiol, 2011. 58(19): p. 1945-54.
20. Price, M.J., et al., Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial. JAMA, 2011. 305(11): p. 1097-105.
21. Wiviott, S.d., et al., Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38). Am Heart J, 2006. 152(4): p. 627-35.
22. Preobrazhenskii, d.v., [Ticagrelor versus clopidogrel in patients with acute coronary syndromes: results of the PLATO study]. Kardiologiia, 2010. 50(1): p. 68.
23. Steg, P.G., et al., Stent thrombosis with ticagrelor versus clopidogrel in patients with acute coronary syndromes: an analysis from the prospective, randomized PLATO trial. Circulation, 2013. 128(10): p. 1055-65.
24. Gurbel, P.A., et al., Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET/ OFFSET study. Circulation, 2009. 120(25): p. 2577-85.
25. Montalescot, G. and A.W. van ‘t Hof, Prehospital ticagrelor in ST-segment elevation myocardial infarction. N Engl J Med, 2014. 371(24): p. 2339.
